Otonomy Investor Relations Material
Latest events
Q2 2022
Otonomy
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Otonomy Inc
Access all reports
Otonomy Inc. is a biopharmaceutical company focused on the development of therapeutics for the treatment of ear-related disorders. The company leverages proprietary drug delivery technology to create sustained-exposure formulations designed for conditions such as hearing loss, tinnitus, and otitis media. Otonomy’s pipeline includes both investigational therapies and products aimed at addressing unmet medical needs in otology. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
Ticker symbol
OTIC
Country
🇺🇸 United States